Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Kent Balanis Lewandrowski, M.D.

Co-Author

This page shows the publications co-authored by Kent Lewandrowski and Andrew Warshaw.
Connection Strength

1.799
  1. Cyst fluid analysis in the differential diagnosis of pancreatic cysts: a new approach to the preoperative assessment of pancreatic cystic lesions. AJR Am J Roentgenol. 1995 Apr; 164(4):815-9.
    View in: PubMed
    Score: 0.153
  2. Cyst fluid analysis in the differential diagnosis of pancreatic cysts. A comparison of pseudocysts, serous cystadenomas, mucinous cystic neoplasms, and mucinous cystadenocarcinoma. Ann Surg. 1993 Jan; 217(1):41-7.
    View in: PubMed
    Score: 0.131
  3. Diagnosis of pancreatic cystic neoplasms: a report of the cooperative pancreatic cyst study. Gastroenterology. 2004 May; 126(5):1330-6.
    View in: PubMed
    Score: 0.072
  4. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 35-2003. A 75-year-old man with a cystic lesion of the pancreas. N Engl J Med. 2003 Nov 13; 349(20):1954-61.
    View in: PubMed
    Score: 0.070
  5. Specific therapy for local and systemic complications of acute pancreatitis with monoclonal antibodies against ICAM-1. Ann Surg. 1999 Jun; 229(6):834-40; discussion 841-2.
    View in: PubMed
    Score: 0.051
  6. Measurement of pS2 protein in pancreatic cyst fluids. Evidence for a potential role of pS2 protein in the pathogenesis of mucinous cystic tumors. Int J Pancreatol. 1998 Dec; 24(3):181-6.
    View in: PubMed
    Score: 0.049
  7. On the protective mechanisms of nitric oxide in acute pancreatitis. Gut. 1998 Sep; 43(3):401-7.
    View in: PubMed
    Score: 0.049
  8. Prevalence of activating K-ras mutations in the evolutionary stages of neoplasia in intraductal papillary mucinous tumors of the pancreas. Ann Surg. 1997 Oct; 226(4):491-8; discussion 498-500.
    View in: PubMed
    Score: 0.046
  9. Cytologic diagnosis of pancreatic cystic lesions. A prospective study of 28 percutaneous aspirates. Acta Cytol. 1997 Jul-Aug; 41(4):972-80.
    View in: PubMed
    Score: 0.045
  10. Pancreatic injury in rats induced by fatty acid ethyl ester, a nonoxidative metabolite of alcohol. Gastroenterology. 1997 Jul; 113(1):286-94.
    View in: PubMed
    Score: 0.045
  11. Pancreatic mucinous ductal ectasia and intraductal papillary neoplasms. A single malignant clinicopathologic entity. Ann Surg. 1997 Jun; 225(6):637-44; discussion 644-6.
    View in: PubMed
    Score: 0.045
  12. Differing roles of nitric oxide in the pathogenesis of acute edematous versus necrotizing pancreatitis. Surgery. 1997 Jan; 121(1):23-30.
    View in: PubMed
    Score: 0.043
  13. Peritoneal fluid cytology in advanced mucinous cystadenocarcinoma of the pancreas. Acta Cytol. 1996 Mar-Apr; 40(2):191-5.
    View in: PubMed
    Score: 0.041
  14. DNA ploidy analysis of mucinous cystic tumors of the pancreas. Correlation of aneuploidy with malignancy and poor prognosis. Cancer. 1996 Jan 01; 77(1):58-62.
    View in: PubMed
    Score: 0.040
  15. Antibiotic treatment improves survival in experimental acute necrotizing pancreatitis. Gastroenterology. 1996 Jan; 110(1):232-40.
    View in: PubMed
    Score: 0.040
  16. Proliferation tissue polypeptide antigen distinguishes malignant mucinous cystadenocarcinomas from benign cystic tumors and pseudocysts. Am J Surg. 1996 Jan; 171(1):126-9; discussion 129-30.
    View in: PubMed
    Score: 0.040
  17. Acute hypercalcemia causes acute pancreatitis and ectopic trypsinogen activation in the rat. Gastroenterology. 1995 Jul; 109(1):239-46.
    View in: PubMed
    Score: 0.039
  18. Cyst fluid NB/70K concentration and leukocyte esterase: two new markers for differentiating pancreatic serous tumors from pseudocysts. Pancreas. 1995 May; 10(4):342-6.
    View in: PubMed
    Score: 0.039
  19. Increased intrapancreatic trypsinogen activation in ischemia-induced experimental pancreatitis. Ann Surg. 1995 Apr; 221(4):364-71.
    View in: PubMed
    Score: 0.038
  20. Relation of epidermal growth factor receptor and estrogen receptor-independent pS2 protein to the malignant transformation of mucinous cystic neoplasms of the pancreas. Arch Surg. 1995 Jan; 130(1):69-72.
    View in: PubMed
    Score: 0.038
  21. Late histopathologic changes and healing in an improved rodent model of acute necrotizing pancreatitis. Digestion. 1995; 56(3):246-52.
    View in: PubMed
    Score: 0.038
  22. Exocrine hyperstimulation but not pancreatic duct obstruction increases the susceptibility to alcohol-related pancreatic injury. Arch Surg. 1994 Oct; 129(10):1081-5.
    View in: PubMed
    Score: 0.037
  23. Time course of bacterial infection of the pancreas and its relation to disease severity in a rodent model of acute necrotizing pancreatitis. Ann Surg. 1994 Aug; 220(2):193-8.
    View in: PubMed
    Score: 0.037
  24. Evidence for extraluminal trypsinogen activation in three different models of acute pancreatitis. Surgery. 1994 Jun; 115(6):698-702.
    View in: PubMed
    Score: 0.036
  25. [Trypsinogen activation peptides in acute pancreatitis. Experimental data and clinical implications]. Chirurg. 1994 Mar; 65(3):186-9.
    View in: PubMed
    Score: 0.036
  26. Pancreatic cystic islet-cell tumors. Clinical and pathologic features in two cases with cyst fluid analysis. Int J Pancreatol. 1994 Feb; 15(1):75-9.
    View in: PubMed
    Score: 0.035
  27. Expression of CA 72-4 (TAG-72) in the fluid contents of pancreatic cysts. A new marker to distinguish malignant pancreatic cystic tumors from benign neoplasms and pseudocysts. Ann Surg. 1994 Feb; 219(2):131-4.
    View in: PubMed
    Score: 0.035
  28. Intravenous contrast medium accentuates the severity of acute necrotizing pancreatitis in the rat. Gastroenterology. 1994 Jan; 106(1):207-14.
    View in: PubMed
    Score: 0.035
  29. Expression of CA 15.3 protein in the cyst contents distinguishes benign from malignant pancreatic mucinous cystic neoplasms. Surgery. 1994 Jan; 115(1):52-5.
    View in: PubMed
    Score: 0.035
  30. Variability in cyst fluid carcinoembryonic antigen level, fluid viscosity, amylase content, and cytologic findings among multiple loculi of a pancreatic mucinous cystic neoplasm. Am J Clin Pathol. 1993 Oct; 100(4):425-7.
    View in: PubMed
    Score: 0.035
  31. Hyperoncotic ultrahigh molecular weight dextran solutions reduce trypsinogen activation, prevent acinar necrosis, and lower mortality in rodent pancreatitis. Am J Surg. 1993 Jan; 165(1):40-4; discussion 45.
    View in: PubMed
    Score: 0.033
  32. Trypsinogen-activation peptides in experimental rat pancreatitis: prognostic implications and histopathologic correlates. Gastroenterology. 1992 Sep; 103(3):1009-16.
    View in: PubMed
    Score: 0.032
  33. Macrocystic serous cystadenoma of the pancreas: a morphologic variant differing from microcystic adenoma. Hum Pathol. 1992 Aug; 23(8):871-5.
    View in: PubMed
    Score: 0.032
  34. A better model of acute pancreatitis for evaluating therapy. Ann Surg. 1992 Jan; 215(1):44-56.
    View in: PubMed
    Score: 0.031
  35. Generation and possible significance of trypsinogen activation peptides in experimental acute pancreatitis in the rat. Pancreas. 1992; 7(3):263-70.
    View in: PubMed
    Score: 0.031
  36. Cystic tumors of the pancreas. New clinical, radiologic, and pathologic observations in 67 patients. Ann Surg. 1990 Oct; 212(4):432-43; discussion 444-5.
    View in: PubMed
    Score: 0.028
  37. Decreased inflammation and improved survival with recombinant human activated protein C treatment in experimental acute pancreatitis. Arch Surg. 2006 Jul; 141(7):670-6; discussion 676-7.
    View in: PubMed
    Score: 0.021
  38. Alcoholic pancreatitis in rats: injury from nonoxidative metabolites of ethanol. Am J Physiol Gastrointest Liver Physiol. 2002 Jul; 283(1):G65-73.
    View in: PubMed
    Score: 0.016
  39. Regional effects of nafamostat, a novel potent protease and complement inhibitor, on severe necrotizing pancreatitis. Surgery. 2001 Aug; 130(2):175-81.
    View in: PubMed
    Score: 0.015
  40. Trypsin and activation of circulating trypsinogen contribute to pancreatitis-associated lung injury. Am J Physiol. 1999 11; 277(5):G1008-16.
    View in: PubMed
    Score: 0.013
  41. Interstitial trypsinogen release and its relevance to the transformation of mild into necrotizing pancreatitis in rats. Gastroenterology. 1999 Sep; 117(3):717-25.
    View in: PubMed
    Score: 0.013
  42. Lexipafant fails to improve survival in severe necrotizing pancreatitis in rats. Int J Pancreatol. 1998 Apr; 23(2):101-6.
    View in: PubMed
    Score: 0.012
  43. Calcium administration augments pancreatic injury and ectopic trypsinogen activation after temporary systemic hypotension in rats. Anesthesiology. 1995 Dec; 83(6):1266-73.
    View in: PubMed
    Score: 0.010
  44. Failure of pentoxifylline to ameliorate severe acute pancreatitis in the rat: results of a prospective, randomized, controlled study. Crit Care Med. 1994 Dec; 22(12):1960-3.
    View in: PubMed
    Score: 0.009
  45. Cyst fluid cytologic analysis in the differential diagnosis of pancreatic cystic lesions. Am J Clin Pathol. 1994 Apr; 101(4):483-7.
    View in: PubMed
    Score: 0.009
  46. Gut macromolecular permeability in pancreatitis correlates with severity of disease in rats. Gastroenterology. 1993 Mar; 104(3):890-5.
    View in: PubMed
    Score: 0.008
  47. Resection margins in carcinoma of the head of the pancreas. Implications for radiation therapy. Ann Surg. 1993 Feb; 217(2):144-8.
    View in: PubMed
    Score: 0.008
  48. Histopathologic correlates of serum amylase activity in acute experimental pancreatitis. Dig Dis Sci. 1992 Sep; 37(9):1426-33.
    View in: PubMed
    Score: 0.008
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.